TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Eagle Pharmaceuticals, Inc. (NADAQ: EGRX) Investor Files Securities Class Action Lawsuit 12/11/2023

  • If you purchased a significant amount of shares of Eagle Pharmaceuticals, Inc. (NADAQ: EGRX) between August 8, 2023 and November 28, 2023, and / or if you purchased any NADAQ: EGRX shares prior to August 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: February 09, 2024. NADAQ: EGRX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 11, 2025 - An amended complaint was filed. December 11, 2023 - An investor in shares of Eagle Pharmaceuticals, Inc. (NADAQ: EGRX) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Eagle Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between August 8, 2023...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)